Log In
Print
BCIQ
Print
Print this Print this
 

ertapenem sodium (Invanz) (L-749345, MK-826)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionBeta-lactam antibiotic
Molecular Target Penicillin binding proteins (PBP)
Mechanism of ActionCell wall synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBacterial infection
Indication DetailsProphylaxis of surgical site infection following elective colorectal surgery; Treat diabetic foot infections of the skin and soft tissue; Treat moderate to severe complicated foot infection in diabetic patients with osteomyelitis; Treat moderate to severe Gram-positive and Gram-negative aerobic and anaerobic bacterial infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today